Comprehensive Stock Comparison

Compare Kimberly-Clark Corporation (KMB) vs Colgate-Palmolive Company (CL) Stock

Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.

Tickers 2 / 10100+ Metrics

Selected Stocks

Add up to 10 tickers. Use presets or search to get started.

2 / 10
Try these comparisons:

Quick Verdict

CategoryWinnerWhy
GrowthCL1.4% revenue growth vs KMB's -14.2%
ValueKMBLower P/E (14.7x vs 25.7x)
Quality / MarginsKMB11.7% net margin vs CL's 10.5%
Stability / SafetyCLBeta 0.02 vs KMB's 0.04
DividendsKMB4.5% yield, 27-year raise streak, vs CL's 2.3%
Momentum (1Y)CL+11.0% vs KMB's -18.0%
Efficiency (ROA)CL13.0% ROA vs KMB's 11.7%, ROIC 43.4% vs 23.2%
Bottom line: CL leads in 4 of 7 categories, making it the stronger pick for investors who prioritize growth and revenue expansion and capital preservation and lower volatility. Kimberly-Clark Corporation is the better choice for valuation and capital efficiency and profitability and margin quality. As direct sector peers, they can serve as alternatives in the same portfolio allocation.

Who Each Stock Is For

Income & stability

Growth exposure

Long-term compounding (10Y)

Sleep-well-at-night portfolio

Defensive / Recession hedge

Business Model

What each company does and how it makes money

KMBKimberly-Clark Corporation
Consumer Defensive

Kimberly-Clark is a global manufacturer of personal care and consumer tissue products sold under well-known brands like Huggies, Kleenex, and Scott. It generates revenue primarily through three segments: Personal Care (~50% of sales), Consumer Tissue (~35%), and K-C Professional (~15%), selling to retailers, distributors, and commercial customers. The company's competitive advantage lies in its powerful portfolio of essential household brands with strong consumer loyalty and extensive global distribution networks.

CLColgate-Palmolive Company
Consumer Defensive

Colgate-Palmolive is a global consumer goods company that manufactures and sells oral care, personal care, home care, and pet nutrition products. It generates revenue primarily from its Oral, Personal and Home Care segment — which contributes roughly 85% of sales — and its Pet Nutrition segment, which makes up the remaining 15%. The company's competitive advantage lies in its powerful global brand portfolio, particularly the dominant Colgate brand in oral care, and its extensive distribution network reaching over 200 countries.

Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

KMBKimberly-Clark Corporation
FY 2024
Consumer Tissue
100.0%$6.2B
CLColgate-Palmolive Company
FY 2024
Oral, Personal and Home Care
77.7%$15.6B
Pet Nutrition
22.3%$4.5B

Financial Metrics Comparison

Side-by-side fundamentals across 2 stocks. BestLagging

Financial Scorecard

CL 4KMB 2
Financial MetricsCL4/6 metrics
Valuation MetricsKMB5/6 metrics
Profitability & EfficiencyCL6/9 metrics
Total ReturnsCL6/6 metrics
Risk & VolatilityCL2/2 metrics
Analyst OutlookKMB2/2 metrics

CL leads in 4 of 6 categories (Financial Metrics, Profitability & Efficiency). KMB leads in 2 (Valuation Metrics, Analyst Outlook).

Financial Metrics (TTM)

CL and KMB operate at a comparable scale, with $20.4B and $17.2B in trailing revenue. Profitability is closely matched — net margins range from 11.7% (KMB) to 10.5% (CL). On growth, CL holds the edge at +5.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricKMBKimberly-Clark Co…CLColgate-Palmolive…
RevenueTrailing 12 months$17.2B$20.4B
EBITDAEarnings before interest/tax$3.3B$3.9B
Net IncomeAfter-tax profit$2.0B$2.1B
Free Cash FlowCash after capex$2.4B$3.6B
Gross MarginGross profit ÷ Revenue+35.6%+60.1%
Operating MarginEBIT ÷ Revenue+14.5%+21.3%
Net MarginNet income ÷ Revenue+11.7%+10.5%
FCF MarginFCF ÷ Revenue+13.8%+17.8%
Rev. Growth (YoY)Latest quarter vs prior year-17.2%+5.8%
EPS Growth (YoY)Latest quarter vs prior year+11.9%-105.1%
CL leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

At 18.4x trailing earnings, KMB trades at a 51% valuation discount to CL's 37.7x P/E. On an enterprise value basis, KMB's 14.0x EV/EBITDA is more attractive than CL's 17.4x.

MetricKMBKimberly-Clark Co…CLColgate-Palmolive…
Market CapShares × price$37.0B$79.9B
Enterprise ValueMkt cap + debt − cash$43.5B$86.6B
Trailing P/EPrice ÷ TTM EPS18.36x37.70x
Forward P/EPrice ÷ next-FY EPS est.14.71x25.66x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple14.00x17.40x
Price / SalesMarket cap ÷ Revenue2.15x3.92x
Price / BookPrice ÷ Book value/share21.12x220.31x
Price / FCFMarket cap ÷ FCF22.57x21.99x
KMB leads this category, winning 5 of 6 comparable metrics.

Profitability & Efficiency

CL delivers a 5.8% return on equity — every $100 of shareholder capital generates $6 in annual profit, vs $115 for KMB. KMB carries lower financial leverage with a 4.08x debt-to-equity ratio, signaling a more conservative balance sheet compared to CL's 21.88x. On the Piotroski fundamental quality scale (0–9), CL scores 6/9 vs KMB's 5/9, reflecting solid financial health.

MetricKMBKimberly-Clark Co…CLColgate-Palmolive…
ROE (TTM)Return on equity+115.0%+5.8%
ROA (TTM)Return on assets+11.7%+13.0%
ROICReturn on invested capital+23.2%+43.4%
ROCEReturn on capital employed+25.3%+41.6%
Piotroski ScoreFundamental quality 0–956
Debt / EquityFinancial leverage4.08x21.88x
Net DebtTotal debt minus cash$6.5B$6.7B
Cash & Equiv.Liquid assets$688M$1.3B
Total DebtShort + long-term debt$7.2B$8.0B
Interest CoverageEBIT ÷ Interest expense9.73x12.37x
CL leads this category, winning 6 of 9 comparable metrics.

Total Returns (with DRIP)

A $10,000 investment in CL five years ago would be worth $14,394 today (with dividends reinvested), compared to $10,537 for KMB. Over the past 12 months, CL leads with a +11.0% total return vs KMB's -18.0%. The 3-year compound annual growth rate (CAGR) favors CL at 12.8% vs KMB's 0.3% — a key indicator of consistent wealth creation.

MetricKMBKimberly-Clark Co…CLColgate-Palmolive…
YTD ReturnYear-to-date+9.9%+28.3%
1-Year ReturnPast 12 months-18.0%+11.0%
3-Year ReturnCumulative with dividends+0.8%+43.4%
5-Year ReturnCumulative with dividends+5.4%+43.9%
10-Year ReturnCumulative with dividends+19.1%+78.5%
CAGR (3Y)Annualised 3-year return+0.3%+12.8%
CL leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

CL is the less volatile stock with a 0.02 beta — it tends to amplify market swings less than KMB's 0.04 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CL currently trades 99.0% from its 52-week high vs KMB's 74.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricKMBKimberly-Clark Co…CLColgate-Palmolive…
Beta (5Y)Sensitivity to S&P 5000.04x0.02x
52-Week HighHighest price in past year$150.45$100.18
52-Week LowLowest price in past year$96.26$74.55
% of 52W HighCurrent price vs 52-week peak+74.1%+99.0%
RSI (14)Momentum oscillator 0–10066.568.5
Avg Volume (50D)Average daily shares traded5.0M5.7M
CL leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Wall Street rates KMB as "Hold" and CL as "Hold". Consensus price targets imply 10.4% upside for KMB (target: $123) vs -6.7% for CL (target: $92). For income investors, KMB offers the higher dividend yield at 4.47% vs CL's 2.27%.

MetricKMBKimberly-Clark Co…CLColgate-Palmolive…
Analyst RatingConsensus buy/hold/sellHoldHold
Price TargetConsensus 12-month target$123.00$92.45
# AnalystsCovering analysts3143
Dividend YieldAnnual dividend ÷ price+4.5%+2.3%
Dividend StreakConsecutive years of raises275
Dividend / ShareAnnual DPS$4.98$2.25
Buyback YieldShare repurchases ÷ mkt cap+0.4%+1.5%
KMB leads this category, winning 2 of 2 comparable metrics.

Historical Charts

Charts are rendered on first load. Hover for details.

Chart 1Total Return — 5 Years (Rebased to 100)

StockMar 20Feb 26Change
Kimberly-Clark Corp… (KMB)10070.52-29.5%
Colgate-Palmolive C… (CL)100126.85+26.8%

Colgate-Palmolive C… (CL) returned +44% over 5 years vs Kimberly-Clark Corp… (KMB)'s +5%. A $10,000 investment in CL 5 years ago would be worth $14,394 today (including dividends reinvested).

Chart 2Revenue Growth — 10 Years

Stock20162025Change
Kimberly-Clark Corp… (KMB)$18.2B$17.2B-5.4%
Colgate-Palmolive C… (CL)$15.2B$20.4B+34.1%

Kimberly-Clark Corporation's revenue grew from $18.2B (2016) to $17.2B (2025) — a -0.6% CAGR. Colgate-Palmolive Company's revenue grew from $15.2B (2016) to $20.4B (2025) — a 3.3% CAGR.

Chart 3Net Margin Trend — 10 Years

Stock20162025Change
Kimberly-Clark Corp… (KMB)11.9%11.7%-1.4%
Colgate-Palmolive C… (CL)16.1%10.5%-34.9%

Kimberly-Clark Corporation's net margin went from 12% (2016) to 12% (2025). Colgate-Palmolive Company's net margin went from 16% (2016) to 10% (2025).

Chart 4P/E Ratio History — 9 Years

Stock20172025Change
Kimberly-Clark Corp… (KMB)18.916.6-12.2%
Colgate-Palmolive C… (CL)33.130-9.4%

Kimberly-Clark Corporation has traded in a 17x–28x P/E range over 9 years; current trailing P/E is ~18x. Colgate-Palmolive Company has traded in a 22x–37x P/E range over 9 years; current trailing P/E is ~38x.

Chart 5EPS Growth — 10 Years

Stock20162025Change
Kimberly-Clark Corp… (KMB)5.996.07+1.3%
Colgate-Palmolive C… (CL)2.722.63-3.3%

Kimberly-Clark Corporation's EPS grew from $5.99 (2016) to $6.07 (2025) — a 0% CAGR. Colgate-Palmolive Company's EPS grew from $2.72 (2016) to $2.63 (2025) — a -0% CAGR.

Chart 6Free Cash Flow — 5 Years

2021
$2B
$3B
2022
$2B
$2B
2023
$3B
$3B
2024
$3B
$4B
2025
$2B
$4B
Kimberly-Clark Corp… (KMB)Colgate-Palmolive C… (CL)

Kimberly-Clark Corporation generated $2B FCF in 2025 (-5% vs 2021). Colgate-Palmolive Company generated $4B FCF in 2025 (+32% vs 2021).

Loading custom metrics...

KMB vs CL: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is KMB or CL a better buy right now?

Kimberly-Clark Corporation (KMB) offers the better valuation at 18.4x trailing P/E (14.7x forward), making it the more compelling value choice. Analysts rate Kimberly-Clark Corporation (KMB) a "Hold" — based on 31 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — KMB or CL?

On trailing P/E, Kimberly-Clark Corporation (KMB) is the cheapest at 18.4x versus Colgate-Palmolive Company at 37.7x. On forward P/E, Kimberly-Clark Corporation is actually cheaper at 14.7x.

03

Which is the better long-term investment — KMB or CL?

Over the past 5 years, Colgate-Palmolive Company (CL) delivered a total return of +43.9%, compared to +5.4% for Kimberly-Clark Corporation (KMB). A $10,000 investment in CL five years ago would be worth approximately $14K today (assuming dividends reinvested). Over 10 years, the gap is even starker: CL returned +78.5% versus KMB's +19.1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — KMB or CL?

By beta (market sensitivity over 5 years), Colgate-Palmolive Company (CL) is the lower-risk stock at 0.02β versus Kimberly-Clark Corporation's 0.04β — meaning KMB is approximately 105% more volatile than CL relative to the S&P 500. On balance sheet safety, Kimberly-Clark Corporation (KMB) carries a lower debt/equity ratio of 4% versus 22% for Colgate-Palmolive Company — giving it more financial flexibility in a downturn.

05

Which has better profit margins — KMB or CL?

Kimberly-Clark Corporation (KMB) is the more profitable company, earning 11.7% net margin versus 10.5% for Colgate-Palmolive Company — meaning it keeps 11.7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CL leads at 21.3% versus 14.5% for KMB. At the gross margin level — before operating expenses — CL leads at 60.1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is KMB or CL more undervalued right now?

On forward earnings alone, Kimberly-Clark Corporation (KMB) trades at 14.7x forward P/E versus 25.7x for Colgate-Palmolive Company — 10.9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KMB: 10.4% to $123.00.

07

Which pays a better dividend — KMB or CL?

All stocks in this comparison pay dividends. Kimberly-Clark Corporation (KMB) offers the highest yield at 4.5%, versus 2.3% for Colgate-Palmolive Company (CL).

08

Is KMB or CL better for a retirement portfolio?

For long-horizon retirement investors, Colgate-Palmolive Company (CL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.02), 2.3% yield). Both have compounded well over 10 years (CL: +78.5%, KMB: +19.1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between KMB and CL?

Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. In terms of investment character: KMB is a mid-cap income-oriented stock; CL is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.

💰
Stocks Like

KMB

Income & Dividend Stock

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Net Margin > 7%
  • Dividend Yield > 1.7%
Run This Screen
💰
Stocks Like

CL

Income & Dividend Stock

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 6%
Run This Screen
Custom Screen

Better Than Both

Find stocks that beat KMB and CL on the metrics you choose

Revenue Growth>
%
(KMB: -17.2% · CL: 5.8%)
Net Margin>
%
(KMB: 11.7% · CL: 10.5%)
P/E Ratio<
x
(KMB: 18.4x · CL: 37.7x)